| Autor: |
A A, Kamalov, I A, Aboian, T I, Derevianko, A A, Erkovich, V N, Zhuravlev, B K, Komiakov, B K, Kuz'menko, V L, Medvedev, A I, Novikov, D A, Okhobotov, M É, Sitdykova, O V, Teodorovich, A Iu, Tsukanov, L A, Khodyrev, V N, Mamedov |
| Rok vydání: |
2014 |
| Předmět: |
|
| Zdroj: |
Urologiia (Moscow, Russia : 1999). (3) |
| ISSN: |
1728-2985 |
| Popis: |
The article presents the results of the multicenter clinical comparative open-label trial in three parallel groups, which was aimed to the evaluation of the efficacy and safety ofbiologically active food supplement NefroDoz after extracorporeal shock wave lithotripsy (ESWL) in patients with urolithiasis. NefroDoz was prescribed for the lithokinetic purpose. The study involved 114 patients from different regions of the Russian Federation aged from 18 to 75 years (mean age 45.56 +/- 12.49 years) with a diagnosis of urolithiasis who underwent ESWL. Patients were divided into 3 groups according to the type oftreatment. Evaluation of the effectiveness was performed using data from a blood test, urine analysis, and biochemical blood assay, ultrasound and KUB X-ray. The results showed that NefroDoz has diuretic, anti-inflammatory, and lithokinetic effects, and is effective and safe drug for the patients with urolithiasis who underwent ESWL. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
